Mirae Asset Global Etfs Holdings Ltd. Madrigal Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 14,162 shares of MDGL stock, worth $4.81 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,162
Previous 14,024
0.98%
Holding current value
$4.81 Million
Previous $2.98 Million
46.81%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding MDGL
# of Institutions
335Shares Held
22.3MCall Options Held
960KPut Options Held
940K-
Janus Henderson Group PLC London, X02.21MShares$751 Million0.36% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.04MShares$694 Million38.14% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.03MShares$690 Million9.12% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$678 Million10.03% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$671 Million6.75% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.81B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...